• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于研究p.N515del(c.1543_1545delAAC)变异对MYBPC3功能及肥厚型心肌病发病机制影响的同基因诱导多能干细胞系的产生

Generation of Isogenic iPSC Lines for Studying the Effect of the p.N515del (c.1543_1545delAAC) Variant on MYBPC3 Function and Hypertrophic Cardiomyopathy Pathogenesis.

作者信息

Pavlova Sophia V, Shulgina Angelina E, Minina Julia M, Zakian Suren M, Dementyeva Elena V

机构信息

Federal Research Centre Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.

出版信息

Int J Mol Sci. 2024 Nov 30;25(23):12900. doi: 10.3390/ijms252312900.

DOI:10.3390/ijms252312900
PMID:39684611
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11641397/
Abstract

The clinical significance of numerous cardiovascular gene variants remains to be determined. CRISPR/Cas9 allows for the introduction and/or correction of a certain variant in induced pluripotent stem cells (iPSCs). The resulting isogenic iPSC lines can be differentiated into cardiomyocytes and used as a platform to assess the pathogenicity of the variant. In this study, isogenic iPSC lines were generated for a variant of unknown significance found previously in a patient with hypertrophic cardiomyopathy (HCM), p.N515del (c.1543_1545delAAC) in . The deletion was corrected with CRISPR/Cas9 in the patient-specific iPSCs. The iPSC lines with the corrected deletion in maintained pluripotency and a normal karyotype and showed no off-target CRISPR/Cas9 activity. The isogenic iPSC lines, together with isogenic iPSC lines generated earlier via introducing the p.N515del (c.1543_1545delAAC) variant in of iPSCs of a healthy donor, were differentiated into cardiomyocytes. The cardiomyocytes derived from both panels of the isogenic iPSCs showed an increased size in the presence of the deletion in , which is one of the HCM traits at the cellular level. This finding indicates the effectiveness of these iPSC lines for studying the impact of the variant on HCM development.

摘要

众多心血管基因变异的临床意义仍有待确定。CRISPR/Cas9技术可在诱导多能干细胞(iPSC)中引入和/或校正特定变异。由此产生的同基因iPSC系可分化为心肌细胞,并用作评估该变异致病性的平台。在本研究中,针对先前在一名肥厚型心肌病(HCM)患者中发现的意义不明的变异p.N515del(c.1543_1545delAAC)构建了同基因iPSC系。利用CRISPR/Cas9在患者特异性iPSC中校正了该缺失。校正缺失后的iPSC系保持了多能性和正常核型,且未显示出脱靶的CRISPR/Cas9活性。将这些同基因iPSC系与先前通过在健康供体的iPSC的中引入p.N515del(c.1543_1545delAAC)变异而产生的同基因iPSC系一起分化为心肌细胞。来自这两组同基因iPSC的心肌细胞在存在缺失时均显示出增大的尺寸,这是细胞水平上HCM的特征之一。这一发现表明这些iPSC系在研究该变异对HCM发展的影响方面是有效的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48cd/11641397/871996dae448/ijms-25-12900-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48cd/11641397/8a1e46c264c1/ijms-25-12900-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48cd/11641397/98486c04a9d7/ijms-25-12900-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48cd/11641397/871996dae448/ijms-25-12900-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48cd/11641397/8a1e46c264c1/ijms-25-12900-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48cd/11641397/98486c04a9d7/ijms-25-12900-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48cd/11641397/871996dae448/ijms-25-12900-g003.jpg

相似文献

1
Generation of Isogenic iPSC Lines for Studying the Effect of the p.N515del (c.1543_1545delAAC) Variant on MYBPC3 Function and Hypertrophic Cardiomyopathy Pathogenesis.用于研究p.N515del(c.1543_1545delAAC)变异对MYBPC3功能及肥厚型心肌病发病机制影响的同基因诱导多能干细胞系的产生
Int J Mol Sci. 2024 Nov 30;25(23):12900. doi: 10.3390/ijms252312900.
2
Studying Pathogenetic Contribution of a Variant of Unknown Significance, p.M659I (c.1977G > A) in MYH7, to the Development of Hypertrophic Cardiomyopathy Using CRISPR/Cas9-Engineered Isogenic Induced Pluripotent Stem Cells.使用 CRISPR/Cas9 基因编辑的同源诱导多能干细胞研究 MYH7 基因中 p.M659I(c.1977G > A)意义不明变异对肥厚型心肌病发病机制的影响。
Int J Mol Sci. 2024 Aug 9;25(16):8695. doi: 10.3390/ijms25168695.
3
Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.利用 CRISPR/Cas9 和人诱导多能干细胞确定不确定意义的基因组变异的致病性。
Circulation. 2018 Dec 4;138(23):2666-2681. doi: 10.1161/CIRCULATIONAHA.117.032273.
4
CRISPR/Cas9 gene editing in induced pluripotent stem cells to investigate the feline hypertrophic cardiomyopathy causing MYBPC3/R820W mutation.利用 CRISPR/Cas9 基因编辑技术在诱导多能干细胞中研究导致猫肥厚型心肌病的 MYBPC3/R820W 突变。
PLoS One. 2024 Oct 10;19(10):e0311761. doi: 10.1371/journal.pone.0311761. eCollection 2024.
5
A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay.MYBPC3 中的提前终止密码子突变通过非编码介导的衰变的慢性激活导致肥厚型心肌病。
Circulation. 2019 Feb 5;139(6):799-811. doi: 10.1161/CIRCULATIONAHA.118.034624.
6
Myosin inhibitor reverses hypertrophic cardiomyopathy in genotypically diverse pediatric iPSC-cardiomyocytes to mirror variant correction.肌球蛋白抑制剂可逆转基因多样化的儿科 iPSC 心肌细胞中的肥厚型心肌病,使其与变体纠正相匹配。
Cell Rep Med. 2024 May 21;5(5):101520. doi: 10.1016/j.xcrm.2024.101520. Epub 2024 Apr 19.
7
iPSC-Based Modeling of Variable Clinical Presentation in Hypertrophic Cardiomyopathy.基于 iPSC 的肥厚型心肌病可变临床表现建模。
Circ Res. 2023 Jul 7;133(2):108-119. doi: 10.1161/CIRCRESAHA.122.321951. Epub 2023 Jun 15.
8
Metabolic remodeling and calcium handling abnormality in induced pluripotent stem cell-derived cardiomyocytes in dilated phase of hypertrophic cardiomyopathy with MYBPC3 frameshift mutation.致肥大型心肌病扩张期心肌肌球蛋白结合蛋白 C 基因移码突变诱导多能干细胞源性心肌细胞的代谢重塑和钙处理异常。
Sci Rep. 2024 Jul 4;14(1):15422. doi: 10.1038/s41598-024-62530-0.
9
Generation of bi-allelic MYBPC3 truncating mutant and isogenic control from an iPSC line of a patient with hypertrophic cardiomyopathy.从一名肥厚型心肌病患者的诱导多能干细胞系中生成双等位基因 MYBPC3 截断突变体和同基因对照。
Stem Cell Res. 2021 Aug;55:102489. doi: 10.1016/j.scr.2021.102489. Epub 2021 Aug 5.
10
Generation of induced pluripotent stem cells from an individual with early onset and severe hypertrophic cardiomyopathy linked to MYBPC3: c.772G > A mutation.从一名早发且严重肥厚型心肌病患者诱导多能干细胞的产生与 MYBPC3 相关:c.772G > A 突变。
Hum Cell. 2024 Jul;37(4):1205-1214. doi: 10.1007/s13577-024-01073-y. Epub 2024 May 18.

本文引用的文献

1
Studying Pathogenetic Contribution of a Variant of Unknown Significance, p.M659I (c.1977G > A) in MYH7, to the Development of Hypertrophic Cardiomyopathy Using CRISPR/Cas9-Engineered Isogenic Induced Pluripotent Stem Cells.使用 CRISPR/Cas9 基因编辑的同源诱导多能干细胞研究 MYH7 基因中 p.M659I(c.1977G > A)意义不明变异对肥厚型心肌病发病机制的影响。
Int J Mol Sci. 2024 Aug 9;25(16):8695. doi: 10.3390/ijms25168695.
2
Hypertrophic cardiomyopathy in carriers in aging.衰老携带者中的肥厚型心肌病。
J Cardiovasc Aging. 2024 Jan;4(1). doi: 10.20517/jca.2023.29. Epub 2024 Jan 11.
3
Enhanced myofilament calcium sensitivity aggravates abnormal calcium handling and diastolic dysfunction in patient-specific induced pluripotent stem cell-derived cardiomyocytes with MYH7 mutation.
MYH7 基因突变诱导多能干细胞衍生的心肌细胞中增强的肌球蛋白细丝钙敏感性加重异常钙处理和舒张功能障碍。
Cell Calcium. 2024 Jan;117:102822. doi: 10.1016/j.ceca.2023.102822. Epub 2023 Nov 8.
4
Missense mutations in the central domains of cardiac myosin binding protein-C and their potential contribution to hypertrophic cardiomyopathy.心肌肌球蛋白结合蛋白-C 中心结构域的错义突变及其对肥厚型心肌病的潜在贡献。
J Biol Chem. 2024 Jan;300(1):105511. doi: 10.1016/j.jbc.2023.105511. Epub 2023 Nov 30.
5
An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy.肥厚型心肌病中 MYBPC3 基因突变的研究进展。
Int J Mol Sci. 2023 Jun 22;24(13):10510. doi: 10.3390/ijms241310510.
6
iPSC-Based Modeling of Variable Clinical Presentation in Hypertrophic Cardiomyopathy.基于 iPSC 的肥厚型心肌病可变临床表现建模。
Circ Res. 2023 Jul 7;133(2):108-119. doi: 10.1161/CIRCRESAHA.122.321951. Epub 2023 Jun 15.
7
Gene Editing and Human iPSCs in Cardiovascular and Metabolic Diseases.基因编辑与心血管代谢疾病中的人类诱导多能干细胞
Adv Exp Med Biol. 2023;1396:275-298. doi: 10.1007/978-981-19-5642-3_18.
8
Molecular genetics in 4408 cardiomyopathy probands and 3008 relatives in Norway: 17 years of genetic testing in a national laboratory.4408 名心肌病先证者和 3008 名亲属的分子遗传学研究:国家实验室 17 年的基因检测
Eur J Prev Cardiol. 2022 Oct 18;29(13):1789-1799. doi: 10.1093/eurjpc/zwac102.
9
Deciphering pathogenicity of variants of uncertain significance with CRISPR-edited iPSCs.利用 CRISPR 编辑的 iPSCs 破译意义不明变体的致病性。
Trends Genet. 2021 Dec;37(12):1109-1123. doi: 10.1016/j.tig.2021.08.009. Epub 2021 Sep 8.
10
Cardiac myosin binding protein-C variants in paediatric-onset hypertrophic cardiomyopathy: natural history and clinical outcomes.小儿起病型肥厚型心肌病中心肌球蛋白结合蛋白 C 变异体:自然病史和临床转归。
J Med Genet. 2022 Aug;59(8):768-775. doi: 10.1136/jmedgenet-2021-107774. Epub 2021 Aug 16.